Endometriosis Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Endometriosis 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a te s t  r e p o r t  b y  I M A R C  Gr o u p ,  t i t l e d  " E n d o m e t r io s i s  Ma r k e t :  G l o b a l  
I n d u s t r y  T re n d s ,  S h a re ,  S i z e ,  Gr o w th ,  O p p o r t u n i ty  an d  F o r e ca s t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  e n d o me t r i o s i s  m a rk e t  s i ze  r e a ch e d  U S $  2 . 4  B i l l i o n  i n  2 0 2 3 .
E nd o m e t r i o s i s  r e f e r s  t o  a  me d i c a l  c o nd i t i o n  t h a t  c a u se s  e x c e ss i v e  g r o w th  o f  
Report en d o m e t r i a l  t i s s u e s  i n  v a r i o u s  re g i o n s  o u t s i d e  t h e  u te r u s ,  s u ch  a s  t he  f a l l o p i a n  t u b e ,  
u t e r i n e  c a v i t y ,  a n d  o v a r i e s .  C h r o n i c  pe l v i c  pa i n ,  f a t i g u e ,  b l o a t i n g ,  c o n s t i p a t i o n ,  
i n fe r t i l i t y ,  a n d  d i s c o m fo r t  du r i n g  u r i n a t i o n  a r e  s o m e  o f  t he  c o mm o n  sy m p to m s .  
Highlight and I t  i s  d i a g n o se d  t h r ou g h  p h ys i c a l  e xa m i n a t i o n s  o f  t h e  p e l v i c  r e g i o n  a n d  v a r i o us  i m a g i n g  
t es t s ,  s u c h  a s  u l t r a s ou n d  a n d  m a g ne t i c  r es o n a nc e  i ma g i n g  ( M R I ) .  E n d o me t r i os i s  i s  
Description t r e a t e d  u s i ng  o ve r - t h e - c o u n te r  m e d i c a t i o n s ,  f e r t i l i t y  t r e a t me n t s ,  h o r m o n a l  t h e r a p y ,  a nd  su r g i c a l  p r o c e du r e s .  T h e s e  t re a t me n t s  a i d  i n  a l l e v i a t i n g  pa i n ,  i n c r e a s i ng  t he  c h an c e  o f  
p r e g n a nc y ,  m i n i m i z i n g  c o mp l i c a t i o ns ,  i m p r o v i n g  t h e  o v e r a l l  q u a l i t y  o f  l i f e ,  a n d  
ma n a g i n g  v a r i ou s  s ym p t o ms ,  s uc h  a s  i n f l a mm a t i o n ,  n a u se a ,  an d  s c a r r i n g .
R eq u e s t  f o r  a  P D F  sa m p le  o f  th i s  r ep o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / e nd o m e t r i o s i s - ma r ke t / r e q ue s t s am p l e
Report Description
G l o b a l  E n d o m e t r i o s i s  M a r k e t  T r e n d s :
T h e  r i s i n g  p r e v a l e n c e  o f  e n d o m e t r i o s i s  d u e  t o  g e n e t i c s ,  h o r m o n a l  i m b a l a n c e ,  r e t r o g r a d e  m e n s u r a t i o n ,  i m m u n e  s y s t e m  d y s f u n c t i o n ,  a n d  
e n v i r o n m e n t a l  t o x i n s  i s  o n e  o f  t h e  p r i m a r y  f a c t o r s  d r i v i n g  t h e  m a r k e t  g r o w t h .  I n  a d d i t i o n  t o  t h i s ,  t h e  i n c r e a s i n g  a w a r e n e s s  a m o n g  t h e  
m a s s e s  r e g a r d i n g  e a r l y  d i a g n o s i s  o f  e n d o m e t r i o s i s  t o  p r e v e n t  v a r i o u s  c o m p l i c a t i o n s ,  s u c h  a s  o v a r i a n  c y s t s ,  a d h e s i o n ,  a n d  b l a d d e r  
d y s f u n c t i o n ,  i s  a c t i n g  a s  a n o t h e r  g r o w t h - i n d u c i n g  f a c t o r .  F u r t h e r m o r e ,  r i s i n g  d e m a n d  f o r  m i n i m a l l y  i n v a s i v e  ( M I )  s u r g i c a l  p r o c e d u r e s ,  
s u c h  a s  l a p a r o s c o p y ,  w h i c h  r e d u c e s  p a i n  a n d  s c a r r i n g ,  p r o m o t e  f a s t e r  r e c o v e r y ,  a n d  m i n i m i z e  t h e  r i s k  o f  i n f e c t i o n s ,  b l o o d  l o s s ,  a n d  
s u r g i c a l  c o m p l i c a t i o n s ,  i s  p r o v i d i n g  a n  i m p e t u s  t o  t h e  m a r k e t  g r o w t h .  A d d i t i o n a l l y ,  t h e  r e c e n t  d e v e l o p m e n t  o f  n o n - s u r g i c a l  t r e a t m e n t  
o p t i o n s ,  s u c h  a s  u l t r a s o u n d  t h e r a p y  w h i c h  u t i l i z e s  h i g h - i n t e n s i t y  f o c u s e d  u l t r a s o u n d  ( H I F U )  t o  d e s t r o y  e n d o m e t r i a l  t i s s u e s  a t  h i g h  
p r e c i s i o n  a n d  e l i m i n a t e  t h e  n e e d  f o r  m e d i c a t i o n s  a n d  h o r m o n a l  t r e a t m e n t s ,  i s  p o s i t i v e l y  i n f l u e n c i n g  t h e  m a r k e t  g r o w t h .  M o r e o v e r ,  
g r o w i n g  i n i t i a t i v e s  b y  s e v e r a l  g o v e r n m e n t s  a n d  i n t e r n a t i o n a l  o r g a n i z a t i o n s ,  s u c h  a s  t h e  E n d o m e t r i o s i s  A s s o c i a t i o n  a n d  W o r l d  
E n d o m e t r i a l  S o c i e t y ,  t o  i n c r e a s e  a w a r e n e s s  a n d  i m p r o v e  a c c e s s  t o  c a r e  f o r  w o m e n  a r e  c r e a t i n g  a  p o s i t i v e  o u t l o o k  f o r  m a r k e t  g r o w t h .  
O t h e r  f a c t o r s ,  i n c l u d i n g  r i s i n g  h e a l t h c a r e  e x p e n d i t u r e ,  r a p i d  a d v a n c e m e n t s  i n  d i a g n o s t i c  t e c h n i q u e s ,  a n d  i n c r e a s i n g  i n v e s t m e n t  i n  t h e  
r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  o f  n o v e l  t r e a t m e n t  m e t h o d s ,  a r e  a n t i c i p a t e d  t o  d r i v e  t h e  m a r k e t  g r o w t h .
L o o k i n g  f o r w a r d ,  t h e  m a r k e t  i s  e x p e c t e d  t o  r e a c h  U S $  3 . 7  B i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  C A G R  o f  4 . 7 1 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / e n d o m e t r i o s i s - m a r k e t
Breakup by Type:
• Superfi cial  Per itoneal Lesion
• Endometr ioma
• Deeply Infi lt rat ing Endometriosis
• Others
 
Report Breakup by Diagnosis and Treatment:
• Diagnosis
Segmentation o Ultrasound
o Pelvic Exam
o Laparoscopy
o Magnet ic Resonance Imaging (MRI)
o Hysteroscopy
o Sonohysterography
• Treatment
o Hormonal Therapy
o Pain Management
o Conservat ive Surgery
Breakup by End Users:
• Hospitals
• Homecare
Report • Special i ty Centers
• Others
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in America
• Middle East and Afr ica
• Abbott Laboratories
• AbbVie Inc.
• Bayer AG
Competitive • Debiopharm Group
Landscape • Gedeon Richter P lc
• Kissei  Pharmaceutical  Co. Ltd.
with Key 
• Myovant Sciences GmbH
Players • Sanofi  S.A.
• Teva Pharmaceutical  Industr ies Ltd.
How has the global endometriosis market 
performed so far, and how will it perform in the 
coming years?
What are the drivers, restraints, and opportunities 
in the global endometriosis market?
Key What is the impact of each driver, restraint, and 
opportunity on the global endometriosis market?
Questions 
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive 
endometriosis market?
What is the breakup of the market based on the 
type?
Which is the most attractive type in the 
endometriosis market?
What is the breakup of the market based on the 
diagnosis and treatment?
Which is the most attractive diagnosis and 
treatment in the endometriosis market?
Key 
Questions What is the breakup of the market based on the end users?
Answered in 
Which is the most attractive end users in the 
the Report endometriosis market?
What is the competitive structure of the market?
Who are the key players/companies in the global 
endometriosis market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  E n d o m e t r i o s i s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e
    6 . 1     S u p e r f i c i a l  P e r i t o n e a l  L e s i o n
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     E n d o m e t r i o m a
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     D e e p l y  I n f i l t r a t i n g  E n d o m e t r i o s i s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     O t h e r s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7     M a r k e t  B r e a k u p  b y  D i a g n o s i s  &  T r e a t m e n t
    7 . 1     D i a g n o s i s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  K e y  S e g m e n t s
           7 . 1 . 2 . 1  U l t r a s o u n d
           7 . 1 . 2 . 2  P e l v i c  E x a m
           7 . 1 . 2 . 3  L a p a r o s c o p y
           7 . 1 . 2 . 4  M a g n e t i c  R e s o n a n c e  I m a g i n g  ( M R I )
Table of            7 . 1 . 2 . 5  H y s t e r o s c o p y
           7 . 1 . 2 . 6  S o n o h y s t e r o g r a p h y
        7 . 1 . 3  M a r k e t  F o r e c a s t
Contents     7 . 2     T r e a t m e n t        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  K e y  S e g m e n t s
           7 . 2 . 2 . 1  H o r m o n a l  T h e r a p y
           7 . 2 . 2 . 2  P a i n  M a n a g e m e n t
           7 . 2 . 2 . 3  C o n s e r v a t i v e  S u r g e r y
        7 . 2 . 3  M a r k e t  F o r e c a s t
8     M a r k e t  B r e a k u p  b y  E n d  U s e r s
    8 . 1     H o s p i t a l s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     H o m e c a r e
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /e ndo m et r i o s i s -m a rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]